GB2208798B - Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative - Google Patents

Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative

Info

Publication number
GB2208798B
GB2208798B GB8719670A GB8719670A GB2208798B GB 2208798 B GB2208798 B GB 2208798B GB 8719670 A GB8719670 A GB 8719670A GB 8719670 A GB8719670 A GB 8719670A GB 2208798 B GB2208798 B GB 2208798B
Authority
GB
United Kingdom
Prior art keywords
ascorbic acid
benzylidene
cancer agent
deuterated derivative
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8719670A
Other languages
English (en)
Other versions
GB2208798A (en
GB8719670D0 (en
Inventor
Bernt Borretzen
Rolf Olaf Larsen
John Michael Dornish
Reidar Oftebro
Erik Olai Pettersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Priority to GB8719670A priority Critical patent/GB2208798B/en
Publication of GB8719670D0 publication Critical patent/GB8719670D0/en
Priority to AU25825/88A priority patent/AU614313B2/en
Publication of GB2208798A publication Critical patent/GB2208798A/en
Application granted granted Critical
Publication of GB2208798B publication Critical patent/GB2208798B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8719670A 1987-07-20 1987-07-20 Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative Expired - Lifetime GB2208798B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8719670A GB2208798B (en) 1987-07-20 1987-07-20 Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
AU25825/88A AU614313B2 (en) 1987-07-20 1988-11-23 Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8719670A GB2208798B (en) 1987-07-20 1987-07-20 Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
EP88310908A EP0369079B1 (en) 1988-11-18 1988-11-18 Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer

Publications (3)

Publication Number Publication Date
GB8719670D0 GB8719670D0 (en) 1987-09-30
GB2208798A GB2208798A (en) 1989-04-19
GB2208798B true GB2208798B (en) 1991-06-05

Family

ID=8200292

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8719670A Expired - Lifetime GB2208798B (en) 1987-07-20 1987-07-20 Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative

Country Status (6)

Country Link
EP (1) EP0369079B1 (enExample)
AT (1) ATE79750T1 (enExample)
DE (1) DE3874142T2 (enExample)
ES (1) ES2051864T3 (enExample)
GB (1) GB2208798B (enExample)
GR (1) GR3005531T3 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
DE19603477A1 (de) * 1996-01-31 1997-08-07 Klaus Dr Med Reuter Tumormittel
AU783283B2 (en) * 1999-08-30 2005-10-13 Ester C Company, The Methods and compositions for selective cancer chemotherapy
CN115361945B (zh) * 2020-03-31 2024-11-12 浙江养生堂天然药物研究所有限公司 药物组合及其用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148094A2 (en) * 1983-12-27 1985-07-10 Mutsuyuki Kochi Anti-tumor agent comprising an O-benzylidene-L-ascorbic acid or a salt thereof, and the production of the latter compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249632A4 (en) * 1985-12-05 1988-06-20 American Biotechnology ATHRACYCLINE TYPE OF ANTITUARY WITH L-ASCORBIC ACID.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0148094A2 (en) * 1983-12-27 1985-07-10 Mutsuyuki Kochi Anti-tumor agent comprising an O-benzylidene-L-ascorbic acid or a salt thereof, and the production of the latter compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Cancer Res. 1979, 39, 663-681 *

Also Published As

Publication number Publication date
DE3874142T2 (de) 1993-01-14
GR3005531T3 (enExample) 1993-06-07
ATE79750T1 (de) 1992-09-15
EP0369079B1 (en) 1992-08-26
DE3874142D1 (de) 1992-10-01
GB2208798A (en) 1989-04-19
EP0369079A1 (en) 1990-05-23
GB8719670D0 (en) 1987-09-30
ES2051864T3 (es) 1994-07-01

Similar Documents

Publication Publication Date Title
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
IL87936A0 (en) Polysulfuric acid esters of bis-aldonamides and their derivatives,the preparation and pharmaceutical compositions containing them
NZ226923A (en) 5'-deoxy-5-fluorocytidine derivatives and pharmaceutical compositions
CA2076465A1 (en) Cell binding agent conjugates of analogues and derivatives of cc-1065
IL106750A0 (en) Peg interferon conjugates
EP0459666A3 (en) Medicaments against impotence
GB8629567D0 (en) Therapeutic agents
FR2613859B3 (fr) Silhouette a forme humaine destinee notamment a l'entrainement dans le jeu de football
GR3015431T3 (en) Use of acetyl L-carnitine in the therapeutic treatment of coma.
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
GR3003555T3 (enExample)
GR3005531T3 (enExample)
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
JPS6416790A (en) 6-substituted peneem ester as anti-inflammatory drug and anti-modifying agent
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
CA2167926A1 (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
CA2101548A1 (en) Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
IT8819410A0 (it) Procedimento per fare aumentare l'efficacia della propagazione vegetativa in vitro delle patate.
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
ZA893479B (en) 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid derivatives and their preparation
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
AU569831B2 (en) Therapeutic agent comprising component having molecular weight not less than 5000 in extract from an alga
Law The effect of time constraint on intrinsic motivation
Gallagher The hubris of philosophy: Alcibiades' praise of Socrates in Plato's Symposium

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19950720